{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Vasundhara Rasayans Ltd Valuation Shifts to Fair Amid Mixed Market Performance
Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons, prompting investors to reassess the stock’s price attractiveness in a challenging industry environment.
Why is Vasundhara Rasayans Ltd falling/rising?
On 30-Jan, Vasundhara Rasayans Ltd witnessed a notable intraday price increase of 5.58%, closing at ₹153.25, reflecting a significant rebound despite its challenging longer-term performance metrics.
Vasundhara Rasayans Ltd is Rated Strong Sell
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 26 January 2026, providing investors with the latest perspective on the company’s position.
Vasundhara Rasayans Ltd Stock Hits 52-Week Low at Rs.129.95
Shares of Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to a fresh 52-week low of Rs.129.95 on 23 Jan 2026, marking a significant milestone in the stock’s recent downward trajectory. This new low reflects ongoing pressures on the company’s valuation amid subdued financial performance and sector underperformance.
Vasundhara Rasayans Ltd Falls to 52-Week Low of Rs.136.3 Amidst Continued Underperformance
Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.136.3 today, marking a significant decline amid a broader market downturn and persistent underperformance relative to its peers and benchmarks.
Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.145
Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.145 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector and market benchmarks, reflecting ongoing pressures on its valuation and market sentiment.
Vasundhara Rasayans Ltd is Rated Strong Sell
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into its performance and outlook.
Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3
Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid sustained downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.
Vasundhara Rasayans Ltd Stock Falls to 52-Week Low of Rs.146.3
Vasundhara Rasayans Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.146.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.
Vasundhara Rasayans Ltd is Rated Strong Sell
Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 December 2025, providing investors with the latest insights into its performance and outlook.
Vasundhara Rasayans: Analytical Perspective Shifts Amidst Mixed Financial and Technical Signals
Vasundhara Rasayans, a player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing.
Vasundhara Rasy. Sees Revision in Market Evaluation Amid Mixed Financial Signals
Vasundhara Rasy., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s financial trends, valuation, quality metrics, and technical outlook, highlighting the complexities investors face in assessing smaller-cap stocks within this dynamic sector.
Is Vasundhara Rasy. overvalued or undervalued?
As of December 4, 2025, Vasundhara Rasy. is considered overvalued with a valuation grade of "expensive," a PE Ratio of 13.42, and a year-to-date return of -35.36%, significantly lagging behind its peers and the Sensex.
Why is Vasundhara Rasy. falling/rising?
As of 18-Nov, Vasundhara Rasayans Ltd's stock price is Rs 206.00, down 3.33%, and has underperformed its sector today. Despite a recent 23.39% weekly gain, the stock is down 30.39% year-to-date, indicating volatility and challenges in sustaining upward momentum.
Is Vasundhara Rasy. overvalued or undervalued?
As of November 17, 2025, Vasundhara Rasy. is considered very expensive with a current price of 213.10, a PE ratio of 14.95, and a low PEG ratio of 0.00, suggesting it may be overvalued compared to peers like Solar Industries and Godrej Industries.
Is Vasundhara Rasy. overvalued or undervalued?
As of November 14, 2025, Vasundhara Rasy. is considered overvalued with a valuation grade of expensive, a PE Ratio of 13.73, and a year-to-date return of -33.86%, significantly underperforming compared to the Sensex's gain of 8.22%.
Is Vasundhara Rasy. overvalued or undervalued?
As of November 14, 2025, Vasundhara Rasy. is considered overvalued with a PE ratio of 13.73 and a year-to-date return of -33.86%, despite outperforming the Sensex recently.
Is Vasundhara Rasy. overvalued or undervalued?
As of November 14, 2025, Vasundhara Rasy. is considered overvalued with a PE ratio of 13.73 and an EV to EBITDA of 15.15, showing weaker growth expectations compared to peers, and despite a recent strong weekly performance, it has underperformed year-to-date, indicating that investors should be cautious.
Why is Vasundhara Rasy. falling/rising?
As of 14-Nov, Vasundhara Rasayans Ltd's stock price is rising to Rs 195.75, reflecting a 19.98% increase. Despite a year-to-date decline of 33.86%, the stock has shown strong short-term performance, outperforming its sector and the broader market recently, though long-term concerns about its viability persist.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
